Domenico Tortorella

Search results

• Australia Patent: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Files Application for 'NEUTRALIZING MONOCLONAL ANTIBODIES TO BK VIRUS'

  Kraus, T. & Tortorella, D.

  26/01/24

  1 item of Media coverage

  Press/Media

• Research Conducted at Icahn School of Medicine at Mount Sinai Has Updated Our Knowledge about COVID-19 (An in Vitro Experimental Pipeline To Characterize the Epitope of a Sars-cov-2 Neutralizing Antibody)

  Brambilla, L., Stevens, C., Lee, B., Bajic, G., Tortorella, D. & Sun, W.

  3/01/24

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Reports Findings in Genomics and Genetics (Generation of Host-directed and Virus-specific Antivirals Using Targeted Protein Degradation Promoted By Small Molecules and Viral Rna Mimics)

  Jin, J., Johnson, J. & Tortorella, D.

  13/09/23

  1 item of Media coverage

  Press/Media

• New Cytomegalovirus Study Results from Icahn School of Medicine at Mount Sinai Described [Investigating N-arylpyrimidinamine (Napa) Compounds As Early-stage Inhibitors Against Human Cytomegalovirus]

  Tortorella, D.

  7/02/23

  1 item of Media coverage

  Press/Media

• -SORRENTO THERAPEUTICS ANNOUNCES COVISHIELD (STI-9167), A BROAD-SPECTRUM NEUTRALIZING ANTIBODY, POTENTLY NEUTRALIZES OMICRON AND OMICRON (+R346K) VARIANTS OF SARS-COV-2

  Tortorella, D.

  24/01/22

  1 item of Media coverage

  Press/Media

• Sorrento Therapeutics Announces Covishield (Sti-9167), a Broad-Spectrum Neutralizing Antibody, Potently Neutralizes Omicron and Omicron (+R346k) Variants of Sars-Cov-2

  Tortorella, D.

  22/01/22

  1 item of Media coverage

  Press/Media

• Sorrento Therapeutics Announces Covishield (Sti-9167), A Broad-Spectrum Neutralizing Antibody, Potently Neutralizes Omicron And Omicron (+R346k) Variants Of Sars-Cov-2

  Tortorella, D.

  21/01/22

  1 item of Media coverage

  Press/Media

• Sorrento Therapeutics Announces Covishield (Sti-9167), a Broad-Spectrum Neutralizing Antibody, Potently Neutralizes Omicron and Omicron (+R346k) Variants of Sars-Cov-2

  Tortorella, D.

  21/01/22

  16 items of Media coverage

  Press/Media

• Sorrento Therapeutics Announces Covishield (Sti-9167), a Broad-Spectrum Neutralizing Antibody, Potently Neutralizes Omicron and Omicron (+R346k) Variants of Sars-Cov-2

  Tortorella, D.

  21/01/22

  1 item of Media coverage

  Press/Media

• SORRENTO THERAPEUTICS ANNOUNCES COVISHIELD (STI-9167), A BROAD-SPECTRUM NEUTRALIZING ANTIBODY, POTENTLY NEUTRALIZES OMICRON AND OMICRON (+R346K) VARIANTS OF SARS-COV-2; - COVISHIELD (STI-9167) neutralizing antibody (nAb) was discovered by scientists from

  Tortorella, D.

  20/01/22

  58 items of Media coverage

  Press/Media

• SORRENTO THERAPEUTICS ANNOUNCES COVISHIELD (STI-9167), A BROAD-SPECTRUM NEUTRALIZING ANTIBODY, POTENTLY NEUTRALIZES OMICRON AND OMICRON (+R346K) VARIANTS OF SARS-COV-2

  Tortorella, D.

  20/01/22

  1 item of Media coverage

  Press/Media

• Digital health startups shattered fundraising records last year, backed by bullish venture capital

  Tortorella, D.

  20/01/22

  1 item of Media coverage

  Press/Media

• US Patent Issued to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI on Nov. 30 for "Broadly neutralizing anti-human cytomegalovirus (HCMV) antibodies and methods of use thereof" (New York Inventors)

  Tortorella, D.

  1/12/21

  1 item of Media coverage

  Press/Media